Thursday, January 1, 2026
Today's Print

Tag: Myron Cohen

Regeneron says COVID antibody treatment protects for at least 8 months

A synthetic antibody treatment developed by Regeneron reduced the risk of developing symptomatic COVID by more than 80 percent up to eight months after...
- Advertisement -spot_img
- Advertisement -spot_img